BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.17.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Melanoma Institute Australia
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Phoenix
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261104
DTEND;VALUE=DATE:20261107
DTSTAMP:20260505T061045Z
CREATED:20260505T061045Z
LAST-MODIFIED:20260505T061045Z
UID:10000283-1793750400-1794009599@melanoma.org.au
SUMMARY:ESSO Congress
DESCRIPTION:The Annual Congress of the European Society of Surgical Oncology (ESSO) is the leading event in Europe dedicated to advancing surgical cancer care. \nBringing together oncology surgeons\, researchers\, and healthcare professionals from across the globe\, the ESSO Congress offers a dynamic platform for sharing cutting-edge research\, surgical innovations\, and multidisciplinary approaches to cancer treatment. \nWith a strong focus on education\, collaboration\, and excellence in patient outcomes\, the congress fosters dialogue\, drives progress\, and shapes the future of surgical oncology. \nWith the theme Surgical Oncology without Borders: Innovations and Challenges Worldwide\, we will explore the latest advancements\, global perspectives\, and shared challenges that shape the future of Surgical Oncology around the world. \nLocation: IFEMA Madrid\, Spain \nKey Dates: \nAbstract submission deadline: 6 May 2026\nAbstract review results: 6 July 2026\nEarly registration deadline: 19 August 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/esso_congress/
LOCATION:IFEMA Madrid\, Avda. Del Partenon\, 5\, Madrid\, 28042\, Spain
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/ESSO_2026_1-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261104
DTEND;VALUE=DATE:20261109
DTSTAMP:20260506T001943Z
CREATED:20260505T061518Z
LAST-MODIFIED:20260506T001943Z
UID:10000284-1793750400-1794182399@melanoma.org.au
SUMMARY:SITC Annual Meeting
DESCRIPTION:SITC 2026 is the premier international conference focused on cancer immunotherapy\, bringing together leaders from academia\, regulatory agencies\, government\, and industry for education\, scientific exchange\, and networking. \nThe conference provides a multidisciplinary educational and interactive environment focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy. \nWhy attend SITC 2026? \n\nCutting-edge sessions by IO experts (Don’t miss over 40 sessions on the latest IO research)\nIn-person networking opportunities with IO luminaries\nAccess the latest immuno-oncology research\n\nLocation: Phoenix Convention Center\, Phoenix\, Arizona\, United States \nKey Dates: \nRegular and early career investigator award abstract submission deadline: 25 June 2026\nAbstract notifications: 31 July 2026\nLate-breaking abstract submission deadline: 10 September 2026\nAbstract notifications: 28 September 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/sitc_meeting/
LOCATION:Phoenix Convention Center\, 100 N 3rd Street\, Phoenix\, AZ\, United States
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/SITC_2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261105T170000
DTEND;TZID=America/Halifax:20261105T170000
DTSTAMP:20260804T054123Z
CREATED:20260804T054123Z
LAST-MODIFIED:20260804T054123Z
UID:10000325-1793898000-1793898000@melanoma.org.au
SUMMARY:Melanoma Research Alliance AWARDS
DESCRIPTION:The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for pre-clinical\, translational\, and early clinical research with the potential to produce unusually high impact\, near-term advancements in melanoma prevention\, detection\, diagnosis\, and treatment. \nThis cycle\, proposals will be accepted for Established Investigator Awards\, Academic-Industry Partnership Award (for Established Investigator Awards)\, Young Investigator Awards\, and Pilot Awards. \nMRA plans to support at least $7.9 million in new funding in the 2026-2027 cycle. \nSpecial Opportunities Included in RFP: \n\nAcral Melanoma Established Investigator\, Young Investigator\, and Pilot Awards focused on Advancing Translational Research for Acral Melanoma\nUveal Melanoma Established Investigator\, Young Investigator\, and Pilot Awards focused on Advancing Translational Research for Uveal Melanoma\nEstablished Investigator\, Young Investigator\, and Pilot Awards from applicants based in the United Kingdom (UK)\nEstablished Investigator\, Young Investigator\, and Pilot Awards from applicants based in Israel\n\n\nKey Dates: \n\nAugust 21\, 2026: Letters of Intent (LOI) due for Established Investigator Awards and Established Investigator Academic-Industry Partnership Award\nSeptember 14\, 2026: Eligibility Checklist and Biosketch due for Young Investigator Award applicants\nNovember 5\, 2026: Proposals due for Young Investigator and Pilot Awards\nDecember 10\, 2026: Invited Established Investigator Award full proposals due\nApril 2027: Awardees notified of funding decisions\nJune 1\, 2027: Project Start Date\n\nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mra-awards/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/08/Melanoma_Research_Alliance-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR